These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 30962331)

  • 1.
    Kaushik A; Ammerman NC; Martins O; Parrish NM; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962331
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
    Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus.
    Bax HI; de Vogel CP; Mouton JW; de Steenwinkel JEM
    J Antimicrob Chemother; 2019 Oct; 74(10):2930-2933. PubMed ID: 31236595
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0068922. PubMed ID: 35943269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity
    Li A; He S; Li J; Zhang Z; Li B; Chu H
    Microbiol Spectr; 2023 Jun; 11(3):e0071823. PubMed ID: 37140428
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33288634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Levels of Intrinsic Tetracycline Resistance in Mycobacterium abscessus Are Conferred by a Tetracycline-Modifying Monooxygenase.
    Rudra P; Hurst-Hess K; Lappierre P; Ghosh P
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632012
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Shoen C; Benaroch D; Sklaney M; Cynamon M
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of
    Ignatius EH; Rimal B; Panthi CM; Belz DC; Lippincott CK; Deck DH; Serio AW; Lamichhane G
    mSphere; 2024 Jul; 9(7):e0038124. PubMed ID: 38980071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.
    Pryjma M; Burian J; Thompson CJ
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147
    [No Abstract]   [Full Text] [Related]  

  • 11. Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates
    Nicklas DA; Maggioncalda EC; Story-Roller E; Eichelman B; Tabor C; Serio AW; Keepers TR; Chitra S; Lamichhane G
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0170421. PubMed ID: 34662184
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Cheng A; Tsai YT; Chang SY; Sun HY; Wu UI; Sheng WH; Chen YC; Chang SC
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of new tetracycline analogues omadacycline and eravacycline against clinical isolates of Helicobacter pylori collected in China.
    Yang Y; Bian L; Hang X; Yan C; Huang Y; Ye F; Zhang G; Jin G; Bi H
    Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115129. PubMed ID: 32739761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omadacycline therapy for Mycobacterium abscessus species infections.
    Ingram PR; Jones EE; Allen B; Murray RJ; Keehner TJ; Whitmore TJ
    Intern Med J; 2023 Dec; 53(12):2257-2263. PubMed ID: 36917124
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Zeng W; Zhang X; Liu Y; Zhang Y; Xu M; Wang S; Sun Y; Zhou T; Chen L
    Front Microbiol; 2022; 13():1043736. PubMed ID: 36483205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of tedizolid against the Mycobacterium abscessus complex.
    Compain F; Soroka D; Heym B; Gaillard JL; Herrmann JL; Dorchène D; Arthur M; Dubée V
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):186-189. PubMed ID: 29217419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of plasmid-borne
    Liu X; Liu Y; Ma X; Chen R; Li C; Fu H; Yang Y; Guo K; Zhang X; Liu R; Xu H; Zhu J; Zheng B
    Microbiol Spectr; 2024 Sep; 12(9):e0049624. PubMed ID: 39041815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease.
    Rimal B; Panthi CM; Xie Y; Belz DC; Ignatius EH; Lippincott CK; Deck DH; Serio AW; Lamichhane G
    Tuberculosis (Edinb); 2024 May; 146():102482. PubMed ID: 38364332
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Sun X; Zhang B; Xu G; Chen J; Shang Y; Lin Z; Yu Z; Zheng J; Bai B
    Ann Lab Med; 2021 May; 41(3):293-301. PubMed ID: 33303714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omadacycline pharmacokinetics/pharmacodynamics in the hollow fiber model and clinical validation of efficacy to treat pulmonary Mycobacterium abscessus disease.
    Singh S; Wang JY; Heysell SK; McShane PJ; Wadle C; Shankar P; Huang HL; Pasipanodya J; Boorgula GD; Philley JV; Gumbo T; Srivastava S
    Int J Antimicrob Agents; 2023 Jul; 62(1):106847. PubMed ID: 37187338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.